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Platelet-derived growth factor-D (PDGF-D), normally
expressed in podocytes, mediates mesangial cell proliferation
in vivo. To study this further, we created transgenic mice with
podocyte-specific overexpression of PDGF-D. Hemizygous
mice were grossly indistinguishable from wild-type
littermates through 11 months of age; however, hemizygous
mice older than 4 weeks commonly exhibited increased
cell proliferation within the glomerular tuft. Many
hemizygous mice also developed widespread segmental
glomerulosclerosis and focal extracapillary proliferation with
fibrin/fibrinogen deposition, extensive tubulointerstitial
damage, proteinuria, and renal insufficiency. Electron
microscopy found focal foot process effacement. Renal mRNA
expression of podocin and nephrin, as well as the number of
glomerular WT-1-positive cells, were significantly reduced in
hemizygous compared to wild-type mice, indicating loss and/
or dedifferentation of podocytes. PDGF-A, -B, and both PDGF
receptor chain mRNAs, fibronectin, type IV collagen, RANTES,
MCP-1, and CCR-2 mRNAs were all increased in the renal
cortex of PDGF-D transgenic mice. Only 8.5% of newborn
mice were homozygous overexpressors exhibiting a mortality
rate of 37% at 4 weeks. Thus, podocyte-specific
overexpression of PDGF-D caused mesangioproliferative
disease, glomerulosclerosis, and crescentic
glomerulonephritis. Hence, podocyte-specific growth factor
overexpression can induce paracrine mesangial cell
proliferation upstream of the filtration flow.
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The platelet-derived growth factor (PDGF) system consists of
four PDGF chains: PDGF-A to -D. PDGF-A and -B are secreted
as homo- or heterodimers and bind to and induce PDGF
receptor dimers composed of a- and/or b-chains. Two novel
PDGF isoforms, PDGF-C and -D, are released as homodimers
only.1–3 Whereas PDGF-BB is a ligand for all receptor types,
PDGF-D binds to the PDGF bb-receptor but not to the aa-
receptor.1,2 PDGF-D is produced as a latent factor. Proteolytic
cleavage of a ‘Clr/Cls’, urchin endothelial growth factor-like
protein, and bone morphogenic protein 1 (CUB) domain from
each chain is required for its activation.4 In addition, PDGF-D
differs from PDGF-BB in that its C terminus lacks a basic amino-
acid sequence that mediates binding to the extracellular matrix.4
Recent studies have shown that PDGF-D induces mesangial cell
proliferation in vitro and is overexpressed in mesangioprolifera-
tive glomerulonephritis in vivo.5,6 Hepatic transfection with an
adenoviral vector expressing PDGF-D led to elevated circulating
levels of PDGF-D and induced prominent mesangioproliferative
nephritis in mice, whereas antagonism of PDGF-D in a rat model
of mesangioproliferative disease ameliorated the renal changes.6,7
These four observations establish PDGF-D, similar to PDGF-B, as
an important mediator of mesangioproliferative nephritis in vivo.
In the adult human kidney, PDGF-D is expressed by podo-
cytes, arterial smooth muscle cells, some neointimal smooth
muscle cells of arteriosclerotic vessels, and by smooth muscle
cells of vasa rectae in the medulla.8 In contrast, PDGF-D is not
expressed in podocytes in normal (healthy) mouse kidney. The
glomerular expression of the PDGF receptor b-chain is restricted
to the mesangium and, to a lesser extent, parietal epithelial cells.
In human podocytes, expression of the PDGF b-receptor chain is
absent.9,10 To gain more insight into the role of podocyte-derived
PDGF-D, we generated a transgenic mouse with podocyte-
specific overexpression of PDGF-D.
RESULTS
Generation of transgenic mice with podocyte-specific
overexpression of PDGF-D
A targeting vector was constructed in which the full-length
PDGF-D cDNA, tagged with enhanced green fluorescent
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protein (EGFP), was driven by a 2.5-kb long fragment of the
podocin promoter (Figure 1a). As the podocin promoter is
only active in differentiated podocytes, which cannot be
cultured and transfected successfully, we additionally created
an expression plasmid in which PDGF-D/EGFP generation
was driven by a b-actin promoter. Increased proliferation of
embryonic mouse fibroblasts (NIH3T3) as a marker for
biological activity of PDGF-D fusion protein was specifically
induced only by conditioned media from HEK 293 cells that
overexpressed PDGF-D/EGFP in comparison with control
transfected cells (Figure 1b). Next, the targeting vector was
injected into fertilized oocytes and the transgenic litters were
identified by a PCR reaction (Figure 1c).
Hemizygous mice developed normally during 11 months
and were macroscopically indistinguishable from wild-type
littermates. The distribution between genders was normal but
only 8% of the offspring from matings between hemizygous
mice were homozygous (Table 1). Homozygous mice
exhibited a mortality rate of 37% at 4 weeks.
Intrarenal transgenic PDGF-D/EGFP mRNA was detected
by reverse transcriptase-PCR (RT-PCR) in isolated glomeruli
(Figure 1d). There was also increased glomerular PDGF-D
mRNA expression in transgenic mice in comparison with
wild-type mice (Figure 1d). Western blotting analysis
confirmed the expression of the transgenic PDGF-D/EGFP
fusion protein by detecting the EGFP tag in glomeruli
isolated from hemizygous nonproteinuric transgenic mice,
but not in glomeruli of wild-type mice (Figure 1e). The
protein detected displayed the same molecular weight as the
PDGF-D/EGFP fusion protein when overexpressed in COS7
cells (positive control, Figure 1e), indicating that our
transgenic mice express the full-length fusion protein
enclosing PDGF-D and the EGFP tag. The size of the protein
corresponded to the EGFP-tagged inactive PDGF-D mono-
mer with a CUB domain. In contrast to nonproteinuric mice,
in renal cortex of 8-week-old hemizygous proteinuric mice,
we detected the active form of the transgenic PDGF-D/EGFP
protein with a molecular weight of approximately 44 kDa
(that is, EGFP-tagged PDGF-D without a CUB domain;
Figure 1f).
By immunohistochemistry, the constitutive glomerular
PDGF-D protein expression was easily detectable within
mesangial cells (Figure 1g). At the age of 4 weeks, damaged
glomeruli of transgenic mice contained occasional PDGF-D-
positive cells in podocyte locations (o5% of the glomerular
cells; Figure 1g). No PDGF-D was detectable in urine and
serum samples by enzyme-linked immunosorbent assay (data
not shown). In immortalized mouse podocytes, we demon-
strated that both undifferentiated and differentiated podo-
cytes were, in principle, able to express endogenous PDGF-D
mRNA (Figure 1h).
Apart from renal cortex, transgene PDGF-D/EGFP mRNA
expression was detected in the brain and bladder of
hemizygous transgenic mice (Table 2) but not in the heart,
lung, liver, muscle, colon, thymus, testis, or ovary. In a
minority of animals, we observed transgene expression in the
spleen, stomach, and uterus. Transgene expression in male
and female mice was indistinguishable (Table 2). Although
the transcriptional activity of the 2.5 kb fragment of the
podocin promoter was described to be podocyte specific,11
podocin mRNA expression was also detected in the brain but
not in the bladder of wild-type mice (n¼ 7, data not shown).
Transgenic mice develop proteinuria, glomerulosclerosis, and
crescentic glomerulonephritis
At the age of 7 weeks, 10 of 53 hemizygous mice, but no wild-
type mouse, had developed proteinuria (Figure 2a). Up to 11
weeks of age, wild-type and hemizygous mice without
proteinuria showed normal renal morphology; in particular,
there was no evidence of increased mesangial cell prolifera-
tion or glomerulosclerosis. In contrast, proteinuric mice of
three different founder lines aged 6–26 weeks (expression of
the transgenic PDGF-D/EGFP of founder line F52 and F118
is shown in Figure 2c) exhibited severe glomerular injury,
characterized by focal and segmental glomerulosclerosis and
by focal extracapillary proliferation, as well as by tubuloin-
terstitial damage (Figure 2b). Electron microscopy revealed
widespread podocyte foot process effacement, as well as focal
capillary collapse. Furthermore, a multilayered parietal
epithelium indicative of focal extracapillary proliferation
could be confirmed by electron microscopy (Figure 2d).
The development of proteinuria correlated with trans-
genic PDGF-D/EGFP protein expression in cortical tissue
(Figure 3a). With respect to transgene mRNA, all hemizygous
mice exhibited an increased PDGF-D mRNA expression in
renal cortex tissue (Figure 3b); however, a significant
difference in proteinuric vs nonproteinuric animals could
only be observed in 4-week-old mice (Figure 3c).
The rare surviving homozygous mice expressed transgenic
PDGF-D/EGFP and overexpressed PDGF-D mRNA in the
renal cortex; however, in comparison with proteinuric
hemizygous mice, their levels of transgenic PDGF-D/EGFP
protein were decreased (Figure 3d, and e) and no renal
phenotype developed (data not shown). This suggests that
only homozygous mice with a low level of transgene
translation were viable. To further analyze the phenotype of
homozygous mice, 32 embryos from hemizygous breeding
pairs were killed at day 19.5 of embryonic development.
The genotype distribution followed the Mendelian ratio
(16% wild type, 53% hemizygous, and 31% homozygous)
and no obvious alterations in renal development or
morphology could be observed up to this stage (Figure 3f),
suggesting peripartal lethality from nonrenal causes.
To assess early stages of glomerular damage in this murine
model, we analyzed kidneys from randomly selected 2-, 4-,
6-, and 8-week-old hemizygous PDGF-D transgenic mice.
Whereas cortical renal transgene mRNA expression decreased
in nonproteinuric mice, it increased in those with proteinuria
(Table 3). Transgenic PDGF-D/EGFP protein levels were
increased in proteinuric in comparison with nonproteinuric
4-, 6- and 8-week-old hemizygous mice (Figure 4a).
Crescents occurred in proteinuric transgenic hemizygous
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mice from the age of 4 weeks onward (Table 3). At the age of
2 weeks, glomeruli showed a normal morphology. Starting
at 4 weeks, we observed an increasing mesangial cellu-
larity when compared with wild-type littermates (Figure 4b).
This was accompanied by a significant increase in proliferat-
ing, that is, proliferating cell nuclear antigen (PCNA)-
positive, glomerular cells in proteinuric hemizygous mice in
comparison with nonproteinuric hemizygous mice (Figure 4c).
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The number of 5-bromodeoxyuridine (BrdU)-positive cells
localized inside the glomerular tuft was significantly increased
in hemizygous proteinuric mice and mildly increased in
nonproteinuric hemizygous mice, whereas the number of
BrdU-positive podocytes, as well as the number of infiltrating
T-lymphocytes, neutrophils, and macrophages, was unchanged
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Figure 1 |Generation of a transgenic mouse strain with podocyte-specific overexpression of platelet-derived growth factor-D
(PDGF-D). (a) Targeting vector injected into fertilized B6D2/F1Crl oocytes. The full-length PDGF-D cDNA, tagged with enhanced green
fluorescent protein (EGFP) at the C terminus, is driven by a 2.5-kb fragment of the podocin promoter (AmpR, ampicillin resistance; pUC ori,
plasmid replication origin; mP1-pA, sequence (nucleotides þ 95 to þ 625 relative to CAP site, providing an artificial intron) and
polyadenylation signal of the murine protamine (P1) gene). (b) Verification of the biological activity of the PDGF-D/EGFP fusion protein
in vitro. HEK 293 cells were transfected with pCAGGS-lacZ or pCAGGS-PDGF-D and the supernatant was collected. NIH 3T3 cells were
incubated with the conditioned media, or medium from untransfected cells, and the proliferation was measured. Data are means±s.d.
BrdU, 5-bromodeoxyuridine. *Po0.001 (analysis of variance (ANOVA) with BONFERRONI post hoc test) vs nontransfected cells. yPo0.001
(ANOVA with BONFERRONI post hoc test) vs pCAGGS (lacZ)-transfected cells. (c) The transgenic litters were identified by a PCR reaction in
which wild-type and transgenic PDGF-Ds were amplified (NC, negative control; M1, M2, M3, tail biopsies from three different littermates).
(d) Transgene expression was also qualitatively detected by real-time reverse transcriptase-PCR (RT-PCR) using a PDGF-D/EGFP-specific
probe in RNA from isolated glomeruli (upper panel). A ct value of 40 cycles indicates that the fluorescence signal did not reach the threshold
until cycle 40, and therefore no PCR product was amplified. Data of eight wild-type and eight transgenic mice are shown. Total glomerular
PDGF-D mRNA (that is, endogenous plus transgene mRNA) was detected by real-time RT-PCR and normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH) mRNA (lower panel). Glomerular PDGF-D mRNA is overexpressed in transgenic relative to wild-type
mice (ct value, cycle of the real-time RT-PCR, in which the fluorescence signal reached the threshold). (e) Overexpressed EGFP protein could
be detected by western blot analysis (arrow) using glomerular lysates of hemizygous transgenic or nontransgenic animals. Lysates of COS-7
cells transiently transfected with PDGF-D/EGFP or PDGF-D were used as positive and negative controls, respectively. Loading of the
membrane was controlled by staining with Ponceau S (NC, negative control; PC, positive control; tg, transgene; wt, wild type). One
representative blot out of two blots performed is shown. (f) Transgenic PDGF-D/EGFP protein was detected in the renal cortex of 8-week-
old proteinuric hemizygous transgenic mice by pulldown of the protein with an anti-EGFP antibody and detection in a western blot
using an anti-PDGF-D antibody. Results of two different transgenic mice and four wild-type controls are shown. (g) PDGF-D protein was
detected by immunohistochemistry in proteinuric hemizygous transgenic and wild-type mice. In wild-type mice, PDGF-D is exclusively
expressed by mesangial cells, whereas in proteinuric transgenic mice PDGF-D could be detected in the mesangium and infrequently in
podocytes. In proteinuric hemizygous mice, PDGF-D-positive podocytes, that is, cells at the edge of the glomerular tuft, were counted.
Podocytes expressing PDGF-D could not be detected in wild-type mice. (h) Transcript expression of PDGF-D during the differentiation of
the immortalized mouse podocyte cell line WT5. Podocytes were switched to nonpermissive conditions, RNA was isolated (n¼ 6 each)
at the time points indicated, and endogenous PDGF-D mRNA expression was measured by real-time RT-PCR and normalized to GAPDH as
an internal standard. Data are shown relative to undifferentiated podocytes (day 1).
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(Figure 4d). An increased number of proliferating parietal cells
could be observed in proteinuric but not in nonproteinuric
hemizygous transgenic mice (Figure 4d).
Glomerular extracapillary proliferation (crescents) in the
proteinuric PDGF-D transgenic hemizygous mice was charac-
terized by fibrin/fibrinogen deposition (Figure 5a and b;
Table 4) and the accumulation of type I collagen and
fibronectin (Figure 5c and d and Table 4). The latter was
accompanied by increased mRNA levels of fibronectin and type
IV collagen in the renal cortex (Figure 5e). No de novo
a-smooth muscle actin expression could be observed in the
mesangium of glomeruli containing crescents (data not shown).
The phenotype described above was observed in 3 of 20
screened founder lines (Figure 2b). However, two lines
became extinct, because of reduced fertility of one line and
the restricted number of transgenic offsprings of the second
founder line. In this second line, both transgenic offsprings
developed proteinuria at the age of 7 weeks. Hemizygous,
podocyte-specific PDGF-D transgenic mice of the third
founder line (F90) were fertile, but homozygous mice were
born infrequently (see above). All analyses were performed in
littermates of the third founder line F90.
Podocytes are subject to damage in PDGF-D transgenic
hemizygous mice
Electron microscopy in hemizygous proteinuric PDGF-D
transgenic mice revealed widespread foot process effacement
of the podocytes, whereas the morphology of glomerular
endothelial cells and the basal membrane appeared normal
(Figure 6a). In addition, the cortical mRNA expression of the
podocyte-specific genes podocin and nephrin was reduced in
comparison with wild-type mice (Figure 6b), as was the
number of Wilms’ tumor 1 (WT-1)-positive cells per
glomerular cross-section (Figure 6c), suggesting that podo-
cytes were damaged in hemizygous transgenic mice.
By TUNEL (TdT-mediated dUTP nick end labeling)
staining, an increased number of apoptotic glomerular cells
were detected in hemizygous proteinuric transgenic mice in
comparison with wild-type mice. A fraction of glomerular
apoptotic cells located at the glomerular edge indicating
apoptotic podocytes (Figure 6d).
The renal phenotype seen in our transgenic mice was not
due to an altered expression of members of the vascular
endothelial growth factor (VEGF) system, as mRNA expres-
sion of total VEGF, VEGF receptors (KDR-1 or FLT-1), or
the soluble inhibitory VEGF receptor-1 (sFLT-1; data not
shown), as well as glomerular VEGF protein expression
(Table 4), in hemizygous proteinuric transgenic mice was
similar to that of wild-type controls.
Overexpression of PDGF-D in podocytes is associated
with increased mRNA expression of PDGF isoforms/PDGF
receptors
In transgenic hemizygous mice with proteinuria, the mRNA
expression of PDGF-A and PDGF-B, as well as those of both
PDGF receptor chains a and b, was increased (Figure 7). No
changes of these mRNA species were observed in 4-, 6-, and
8-week-old healthy transgenic mice (data not shown). The
mRNA expression of PDGF-C remained unchanged. As
PDGF-D is a high-affinity ligand for the PDGF receptor
b-chain, we stained for PDGF receptor b-chain protein
in renal tissue. No obvious deviation from the normal
mesangial and parietal epithelial cell receptor staining pattern
was observed in diseased transgenic hemizygous mice (Figure
7b); however, the relative glomerular area staining positively
for the b-chain was increased in proteinuric transgenic mice
in comparison with wild-type mice (Figure 7b and Table 4).
Characterization of crescentic glomerulonephritis in
transgenic mice
Crescentic glomerulonephritis is typically associated with a
strong inflammatory process. Indeed, proteinuric transgenic
hemizygous mice demonstrated increased renal cortical
mRNA levels of proinflammatory chemokines MCP-1
(monocyte chemotactic protein-1) and RANTES (regulated
upon activation, normal T-cell expressed, and secreted), as
well as the chemokine receptor CCR-2 (chemokine (C-C
motif) receptor 2), when compared with wild-type mice
(Figure 8a). The increased mRNA expression of proinflam-
matory chemokines was associated with an increased
accumulation of ER-HR3-positive macrophages within the
multilayer parietal epithelium of injured glomeruli (Figure 8b
and c).
Table 2 | Transgene mRNA expression in different tissues of hemizygous transgenic and wild-type mice
Kidney Heart Lung Liver Muscle Spleen Brain Colon Stomach Bladder Bone marrow Thymus Testis Ovary Uterus
Transgenic
Male 9/9 0/3 0/3 0/3 0/3 2/9 10/10 0/3 1/12 12/12 0/3 0/2 0/3
Female 10/10 0/3 0/3 0/3 0/3 4/9 8/8 0/3 4/11 11/11 0/1 0/3 0/3 4/11
Wild type
Male 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4 0/4
Female 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3 0/3
Bold values indicate tissues in which the transgene was detected.
Table 1 |Mendelian ratio of offspring from breeding between
hemizygous mice
Gender Genotype
Offspring Male Female Wild type Hemizygous Homozygous
N=223 115 (52%) 108 (48%) 66 (30%) 138 (62%) 19 (8%)
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A high percentage of proteinuric mice showed an
accumulation of IgA and IgM in glomeruli, which exhibited
extracapillary proliferation (data not shown). In total, 30 and
40% of the proteinuric mice showed glomerular deposition
of IgG and complement factor C3c, respectively (data not
shown). With the exception of one animal, only mice with
proteinuria exhibited immunoglobulin and C3c deposits.
DISCUSSION
The major finding in our transgenic mouse model was the
development of a proliferative glomerulonephritis. The
podocyte-specific overexpression of PDGF-D resulted in
proliferative changes within the glomerular tuft. Given that
the number of podocytes, as well as infiltrating neutrophils,
macrophages, and T lymphocytes, remained unchanged in
the transgenic mice, the increased glomerular cell prolifera-
tion within the glomerular tuft appears to result from
mesangial and/or endothelial cells, both of which can express
PDGF b-receptors.9,10 In addition, the number of proliferat-
ing parietal epithelial cells was significantly increased in
proteinuric transgenic mice in comparison with nonprotei-
nuric transgenic mice. Our data are in accordance with a
mitogenic effect of PDGF-D in mesangial cells in vitro, as well
as with the observation that systemic overexpression of
PDGF-D using an adenoviral construct directing hepatic
production of PDGF-D resulted in a mesangial proliferative
glomerulopathy.6,7 In addition, PDGF-B, a potent mesangial
cell mitogen, and the PDGF b-receptor were overexpressed in
the cortex of transgenic proteinuric mice. It is likely that this
occurred in the course of mesangioproliferative changes
within the glomerular tuft, as both mesangial and endothelial
cells can express both PDGFs and PDGF receptors.12 This
process might have amplified the mitogenic activity of
PDGF-D on mesangial cells, as well as on parietal epithelial
cells, and it may thus have contributed to crescent formation
as well.12 So far, very little is known about a potential
podocyte–mesangial cell crosstalk. Budde et al.13 demon-
strated that cell-culture medium conditioned by podocytes
induced mesangial cell proliferation in vitro, but PDGF-B
did not seem to be involved, as shown by competition
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Figure 2 |Podocyte-specific overexpression
of platelet-derived growth factor-D (PDGF-D) leads to
increased proteinuria, glomerulosclerosis, and crescentic
glomerulonephritis. (a) Proteinuria was measured in
spontaneous urine samples (n¼ 9 proteinuric transgenic mice
(five male mice (4–8 weeks old) and four female mice (4–7 weeks
old)); n¼ 9 age- and gender-matched wild-type mice, Po0.001
Mann–Whitney U-test). (b) Renal morphological changes in
proteinuric transgenic mice. Glomerulosclerosis and crescentic
glomerulonephritis were observed in periodic acid-Schiff (PAS)-
stained renal sections. Representative findings in proteinuric
transgenic mice were obtained from three different founder lines:
F90 (8-week-old male mouse with glomerulosclerosis score 4), F52
(6-week-old male mouse, score 4), and F118 (26-week-old female
mouse, score 2). Crescents are indicated by arrows. (c) Transgene
expression was detected in founder lines F90 and F52 by anti-
enhanced green fluorescent protein (anti-EGFP) western blot
analysis and PCR analysis. GAPDH, glyceraldehyde 3-phosphate
dehydrogenase. (d) By electron microscopy, multilayer parietal
epithelium could be observed in proteinuric transgenic mice.
pE, parietal epithelia; tg, transgene; wt, wild type.
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experiments. In addition, in that study, the maximal
proliferation rate was reached after an incubation time of
48 h, whereas PDGF-DD and PDGF-BB induce maximal cell
proliferation in mesangial cells after 24 h.5 In contrast to the
findings observed following hepatic overexpression of PDGF-
D,6,7 a considerable number of our transgenic hemizygous
mice developed more severe glomerular injury, characterized
by proteinuria, focal and segmental glomerulosclerosis, and
by focal extracapillary proliferation, as well as by tubulo-
interstitial damage and renal failure. The development of
proliferative glomerulonephritis was not accompanied by an
increased positive glomerular a-smooth muscle actin staining.
This observation is comparable to the one in PDGF-BB-
infused rats, where increased mesangial cell proliferation also
occurred without de novo a-smooth muscle actin expression.14
In particular, the formation of extracapillary cellular
proliferation with many features of crescents can be explained
by paracrine effects of podocyte-derived PDGF-D. Thus,
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Figure 3 | Transgenic platelet-derived growth factor-D/enhanced green fluorescent protein (PDGF-D/EGFP) expression in
proteinuric and nonproteinuric hemizygous and homozygous mice. (a) Increased levels of transgenic PDGF-D/EGFP protein were
detected in proteinuric in comparison with nonproteinuric hemizygous transgenic mice (western blot analysis using an anti-EGFP antibody).
GAPDH, glyceraldehyde 3-phosphate dehydrogenase. (b) Transgene expression was also qualitatively detected by real-time reverse
transcriptase-PCR (RT-PCR) using a PDGF-D/EGFP-specific probe in RNA from cortical tissues of proteinuric and non-proteinuric hemizygous
and wild-type mice (upper panel). A ct value of 40 cycles indicates that the fluorescence signal did not reach the threshold until cycle 40,
and therefore no PCR product was amplified. (c) Total cortical PDGF-D mRNA (that is, endogenous plus transgene mRNA) was detected by
real-time RT-PCR and normalized to GAPDH mRNA (lower panel). An increased cortical PDGF-D mRNA expression in proteinuric in comparison
with nonproteinuric hemizygous mice could be observed in 4-week-old mice. In comparison with wild-type mice, hemizygous transgenic
mice showed a cortical overexpression of PDGF-D mRNA (ct value, cycle of the real-time RT-PCR, in which the fluorescence signal reached the
threshold; n-prot, nonproteinuric, prot, proteinuric, tg, transgene; wt, wild type). (d) Transgenic PDGF-D/EGFP could be detected in three
homozygous mice using real-time RT-PCR. Cortical PDGF-D mRNA expression was increased in homozygous in comparison with wild-type
mice. (e) Decreased transgenic PDGF-D/EGFP concentrations could be detected in surviving homozygous mice (3 weeks old) in comparison
with proteinuric hemizygous mice by western blot analysis. (f) No changes in renal morphology could be observed in PAS-stained sections of
homozygous transgenic mice in comparison with wild-type mice at the age of day 19.5 of embryonic development.
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parietal epithelial cells of Bowman’s capsule have been
described to express the PDGF b-receptor chain in humans
and primates, as well as in cryoglobulinemic mice.10,15
Similarly, the PDGF b-receptor chain has been detected in
glomerular crescents.16,17 Deposition of immunoglobulins
and complement was exclusively observed in our proteinuric
transgenic mice with extracapillary proliferation, but not in
nonproteinuric mice, indicating that it may represent passive
entrapment rather than the pathophysiological origin of the
crescents.
Table 3 | Age-related alterations in proteinuric and nonproteinuric hemizygous transgenic mice
Nonproteinuric Proteinuric
Age
(weeks) n
Proteinuria
(mg/dl)
Transgenic PDGF-
D/EGFP mRNA
expression relative
to 4-week-old mice
% Glomeruli
containing
crescents
Glomerulosclerosis
score n
Proteinuria
(mg/dl)
Transgenic PDGF-D/EGFP
mRNA expression
relative to 4-week-old
mice
% Glomeruli
containing
crescents
Glomerulosclerosis
score
4 9 11±6 1.0±0.5 0 0 4 734±574 1.0±0.1 17±10 1.8±0.5
6 12 22±21 1.1±0.7 0 0 7 416±272 1.6±0.6 39±24 3.0±0.8
8 15 10±6 0.4±0.2 0 0 8 257±174 1.9±1.3 63±17 3.5±0.5
Abbreviations: EGFP, enhanced green fluorescent protein; PDGF-D, platelet-derived growth factor-D.
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Figure 4 |Development of glomerulosclerosis and crescentic glomerulonephritis in transgenic mice. (a) Western blot analysis using an
anti-enhanced green fluorescent protein (anti-EGFP) antibody from proteinuric and nonproteinuric hemizygous mice at the age of 4, 6, and
8 weeks. Increased transgenic platelet-derived growth factor-D (PDGF-D)/EGFP protein levels were observed in cortical tissues from
proteinuric in comparison with nonproteinuric hemizygous mice. Mean values of both animals are shown in the morphometric analysis.
(b) Renal periodic acid-Schiff (PAS)-stained sections from randomly selected transgenic mice at the age of 2, 4, 6, and 8 weeks. Increasing
glomerular cellularity and the formation of extracapillary proliferation can be observed. (c) In proteinuric but not in nonproteinuric
hemizygous mice, an increased number of glomerular proliferating cell nuclear antigen (PCNA)-positive cells can be observed. No significant
alterations in PDGF-D/EGFP mRNA expression could be observed in proteinuric in comparison with nonproteinuric hemizygous mice
(*Po0.05 vs wild type; yPo0.05 vs nonproteinuric hemizygous mice). (d) Randomly selected 6-week-old hemizygous transgenic (n¼ 12)
and wild-type (n¼ 6) mice were labeled with 5-bromodeoxyuridine (BrdU) and the incorporated renal BrdU was detected by
immunohistochemistry. An increased number of BrdU-positive cells could be observed inside the glomerular tuft in hemizygous
nonproteinuric transgenic mice. Immunohistochemical analysis of CD3, Ly6G, and ER-HR3 showed no differences in the number of
infiltrating immune cells inside the glomerular tuft in hemizygous nonproteinuric transgenic mice in comparison with wild-type mice.
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In our transgenic mice, podocyte-specific overexpression
of PDGF-D resulted in a diminished mRNA expression of
podocin and nephrin and a reduced number of glomerular
WT-1-positive cells. These observations are in agreement
with podocyte damage and correspond to findings, for
example, in crescentic glomerulonephritis of other origin,
where podocyte proliferation and the loss of differentiation
markers, such as WT-1, synaptopodin, nephrin, and podocin,
have also been observed.18 The mechanism(s) by which
transgenic expression of PDGF-D in podocytes results in
downregulation of slit diaphragm protein mRNAs currently
remains unknown, but could involve podocyte apoptosis.
The existence of apoptotic podocytes in renal disease
accompanied by downregulation of nephrin expression and
a decreased number of glomerular WT-1-positive cells is well
established in other transgenic mouse models,19 and indeed
the inactivation of podocyte proteins such as podocin may be
causal in this process.20 Importantly, we were able to exclude
the fact that the phenotype of the transgenic mice was
secondary to disturbances of the VEGF system. Thus,
Eremina et al.21,22 demonstrated that podocyte VEGF is
required for mesangial cell survival and differentiation, as
well as for endothelial cell migration, differentiation, and
survival.
One notable feature of our transgenic model is that the
renal phenotype occurred with expression of full-length
PDGF-D in podocytes. Full-length PDGF-D requires proteo-
lytic cleavage of its CUB domain to become biologically
active.1,2 Whereas plasmin exhibits such cleaving activity
in vitro, the protease(s) involved in PDGF-D cleavage in vivo
likely includes urokinase-type plasminogen activator, which
was shown to be expressed in podocytes in vitro.23,24
In our mouse model, the transgene was driven by a
fragment of the podocin promoter, which has been reported
to be podocyte specific.11 Genetic mosaicism may have
contributed to the variable phenotype that we observed in
heterozygote mice. The fact that most homozygous trans-
genic mice apparently died in utero, whereas other homo-
zygotes survived long term with no renal phenotype, also
supports the assumption of genetic mosaicisms and/or
variable transgene penetrance.
Besides glomerular transgene expression, we detected the
PDGF-D/EGFP mRNA in the brain and bladder. Contrary to
prior reports,11 and similar to other ‘podocyte-specific’ genes
such as nephrin and synaptopodin,25,26 we detected podocin
mRNA expression in the brain of wild-type mice, whereas the
bladder was negative. This latter observation suggests that the
detection of the transgene mRNA expression in the bladder
might have resulted from detached transgenic podocytes.
Indeed, loss of podocytes in our transgenic mice was
indicated by the decreased number of glomerular WT-1-
positive cells and the reduced mRNA expression of podocin
and nephrin. It appears very unlikely that the expression of
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Figure 5 |Glomerular extracapillary proliferation in platelet-
derived growth factor-D (PDGF-D) transgenic mice are
characterized by deposition of fibrin/fibrinogen, type I
collagen, and fibronectin. (a) Accumulation of fibrin/fibrinogen
could be observed by immunohistochemistry in the extracapillary
proliferation of the proteinuric transgenic mice. (b) Staining with a
biotinylated goat anti-rabbit antibody confirmed the specificity of
fibrinogen staining (negative control). By immunohistochemistry,
(c) type I collagen and (d) fibronectin also showed an intense
upregulation in the crescents (data are representative of n¼ 10
proteinuric transgenic and n¼ 22 age- and gender-matched wild-
type mice). (e) Type IV collagen and fibronectin mRNA, as
detected by real-time reverse transcriptase-PCR (RT-PCR) and
normalized to glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) mRNA. The gene expression data from proteinuric
transgenic (n¼ 10) and age- and gender-matched wild-type mice
(n¼ 6) are shown (tg, transgene; wt, wild type); Po0.001,
Mann–Whitney U-test.
Table 4 | Immunohistochemical characterization of
proteinuric hemizygous transgenic mice
Protein Wild-type mice Transgenic mice P-value
PDGFR-b 3.3±2.4 9.3±4.1 0.016
Fibrin/fibrinogen 1.1±1.1 16.2±7.7 0.014
Fibronectin 3.3±1.8 16.6±7.7 0.009
Collagen type I 0.36±0.2 9.7±2.1 0.009
VEGF 0.95±0.8 0.64±0.3 Not significant
Abbreviations: PDGFR-b, platelet-derived growth factor receptor-b; VEGF, vascular
endothelial growth factor.
Numbers depict percent positively stained glomerular area relative to the total
glomerular area. Parietal epithelium was excluded in this analysis. n=5 proteinuric
(4–8 weeks old) and n=5 wild-type mice (4–8 weeks old).
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the transgene in the brain accounted for the findings of the
present study as we consistently failed to detect PDGF-D in
sera of transgenic animals (data not shown).
The same renal phenotype was observed in three different
founder lines. This suggests that the phenotype is related to
podocyte-specific overexpression of PDGF-D and not by the
destruction of any other gene. Final proof for the pathophy-
siological role of PDGF-D in our mice was sought after by
performing a rescue experiment using injections of an
inhibitory anti-PDGF-D antibody from 3 weeks of age.
However, this experiment failed (data not shown) because of
the high variability of the mouse phenotypes, which in turn
likely relates to the genetic mosaic (see above).
In conclusion, we present a novel model of murine
glomerulonephritis in which podocyte-specific overexpres-
sion of PDGF-D leads to mesangioproliferative disease,
glomerulosclerosis, and crescentic glomerulonephritis. More
generally, we provide the first evidence that podocyte-specific
overexpression of a growth factor is capable of inducing
paracrine cell proliferation inside the glomerular tuft up-
stream of the filtration flow, as well as proliferation of
parietal glomerular epithelial cells. It is noteworthy that
mesangial expansion can accompany podocyte damage in
focal segmental glomerulosclerosis.27 This supports the
hypothesis that podocytes may locally alter their PDGF
release in response to injury, and that this podocyte-derived
PDGF can induce intraglomerular pathology.
MATERIALS AND METHODS
Generation of the transgenic mice strain
All studies were approved by the local institutional review board.
Full-length rat PDGF-D cDNA was amplified in a RT-PCR reaction
from RNA isolated from rat adrenal gland tissue using the following
primers (forward: 50-GGGGTACCCCATGCACCGGCTCATCTTAG
TC-30; reverse: 50-TCCCCCGGGGGAATCGAGGTGGTCTTGAG
CTG-30). The PCR fragment was digested with the restriction
enzymes KpnI and SmaI (both from MBI Fermentas, Burlington,
ON, Canada) and cloned into the KpnI/SmaI-digested vector
pEGFP-N1 (Invitrogen Groningen, The Netherlands). PDGF-D
cDNA tagged with EGFP was amplified (forward primer: 50-ATGCA
CCGGCTCATCTTAGTC-30; reverse primer: 50-CATGCCATGGCAT
GTTACTTGTACAGCTCGTCCAT-30) and ligated into the NcoI
(New England Biolabs, Frankfurt a.M., Germany)-digested vector
pSNlacZ, which contained a 2.5-kb long fragment of the podocin
promoter.11 The PDGF-D sequence was checked for mutations by
sequencing after each cloning step. The targeting vector was digested
with KpnI and SphI (New England Biolabs); the DNA fragment
containing the podocin promoter and the PDGF-D/EGFP sequence
was purified and injected into fertilized B6D2/F1Crl oocytes.
Transgenic litters were identified using a PCR reaction from DNA
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Figure 6 |Podocyte-specific overexpression of platelet-
derived growth factor-D (PDGF-D) results in damage of
podocytes. (a) Electron microscopy showed widespread foot
process fusion in proteinuric transgenic mice. The white frame
indicates the region, which is shown at higher magnification.
(b) Real-time reverse transcriptase-PCR (RT-PCR)-based expression
data of podocin and nephrin normalized to glyceraldehyde
3-phosphate dehydrogenase (GAPDH) mRNA. The figure depicts
the transcript expression in proteinuric transgenic (n¼ 10),
nonproteinuric transgenic (n¼ 11), and wild-type mice (n¼ 6 age-
and gender-matched mice); Po0.001 analysis of variance
(ANOVA), Tukey’s post hoc test. (c) Immunohistochemical analysis
of Wilms’ tumor 1 (WT-1) showed a decreased number of
glomerular WT-1-positive cells in proteinuric transgenic in
comparison with age- and gender-matched wild-type and
nonproteinuric hemizygous mice (n¼ 10 proteinuric transgenic,
n¼ 16 nonproteinuric transgenic, and n¼ 22 wild-type mice; non-
prot, nonproteinuric; prot, proteinuric; wt, wild type), Po0.001
ANOVA, Tukey’s post hoc test. (d) TdT-mediated dUTP nick end
labeling (TUNEL) staining of hemizygous proteinuric transgenic
(tg; n¼ 10) and wild-type (wt) mice (n¼ 10). Apoptotic cells were
counted in the whole glomerular tuft (‘all’) and at the glomerular
edge.
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isolated from tail biopsy using the following primers detecting the
wild-type (forward: 50-GGGGTACCCCATGACTCCCAGGAATCAC
TCGGT-30; reverse: 50-TCCCCGCGGGGATCGAGGTGGTCTTGAG
CTGCA-30) and the transgenic PDGF-D (forward: 50-CAGCGACTC
CACAGGGACT-30; reverse: 50-GTGCCTGTCACCCGAATGTTC-30).
The transgenic mice were bred for two generations with C57BL/6
wild-type mice before analysis. Hemizygous and homozygous
animals were distinguished by real-time PCR with EGFP primers
and an EGFP probe (Table 5) by amplifying DNA isolated from tail
biopsies.
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Figure 7 |Renal cortical mRNA expression of platelet-derived
growth factor (PDGF) isoforms and PDGF receptor chains.
(a) Podocyte-specific overexpression of PDGF-D induced
overexpression of PDGF-A and -B, as well as both PDGF receptor
chains, as measured by real-time reverse transcriptase-PCR (RT-
PCR; data normalized to glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) mRNA). Gene expression data from
proteinuric transgenic (n¼ 10) and age- and gender-matched
wild-type mice (n¼ 6) are shown (tg, transgene; wt, wild type);
Po0.001 Mann–Whitney U-test. (b) PDGFR-b protein and the
podocyte marker Wilms’ tumor 1 (WT-1) were detected in serial
sections from proteinuric hemizygous mice by
immunohistochemistry. In sclerotic glomeruli, an increased
PDGFR-b positively stained glomerular area accompanied by a
reduction or absence of WT-1-positive glomerular cells could be
observed. A normal PDGFR-b staining pattern and a normal
number of WT-1-positive glomerular cells were detected in
unaffected glomeruli of the same animal. A representative image
of a proteinuric hemizygous mouse is shown.
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Figure 8 |Renal cortical mRNA expression of immune
mediators and infiltration of immune cells. (a) Real-time
reverse transcriptase-PCR (RT-PCR)-based expression data of
MCP-1 (monocyte chemotactic protein-1), RANTES (regulated
upon activation, normal T-cell expressed, and secreted), and
CCR-2 (chemokine (C-C motif) receptor 2) normalized to
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA. The
gene expression data from proteinuric transgenic (n¼ 10) and
age- and gender-matched wild-type mice (n¼ 6) are shown;
Po0.001 Mann–Whitney U-test. (b) In crescents of proteinuric
transgenic hemizygous mice, but not in parietal epithelium of
wild-type mice, ER-HR3-positive cells (arrows) could be detected
by immunohistochemistry. (c) In extracapillary proliferates, but
not in parietal epithelium of wild-type mice, ER-HR3-positive cells
could be observed. In this analysis, the glomerular tuft was not
included (tg, transgene; wt, wild type; n¼ 10 proteinuric
transgenic, and n¼ 22 age- and gender-matched wild-type mice);
Po0.001 Mann–Whitney U-test.
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Verification of the biological activity of the PDGF-D/EGFP
fusion protein
HEK 293 cells were transfected with pCAGGS (PDGF-D/EGF), in
which the PDGF-D/EGFP was driven by a b-actin promoter, or the
control plasmid pCAGGS (lacZ) using Fugene Reagent (Roche,
Basel, Switzerland). The supernatant was removed 40 h after
transfection and treated with 0.5 U/ml plasmin for 20 min and
7.6mg/ml aprotinin for 7 min. NIH3T3 cells were seeded in 96-well
plates (Nunc, Wiesbaden, Germany), grown to subconfluence, and
growth-arrested for 48 h in MCDB medium (Sigma-Aldrich,
Taufkirchen, Germany). After 48 h, conditioned media were added
and the cells were incubated for 27 h. DNA synthesis was determined
during the last 21 h by a BrdU incorporation assay according to the
manufacturer’s instructions (Roche, Mannheim, Germany).
Differentiation of an immortalized mouse podocyte cell line
The immortalized mouse podocyte cell line WT5 was cultivated
under permissive conditions at 33 1C as described.28 Differentiation
was induced by incubating the cells under nonpermissive conditions
(37 1C; without g-interferon).
Real-time quantitative RT-PCR
Glomeruli were isolated as described by Takemoto et al.29 Total RNA
was isolated from renal cortex or isolated glomeruli using the
RNeasy Mini Kit (Qiagen, Hilden, Germany). Quantification of the
RNA content and sample purity, cDNA synthesis, and real-time
quantitative RT-PCR were assessed and performed, respectively, as
described.6 All quantitative data from the real-time RT-PCR were
normalized using GAPDH (glyceraldehyde 3-phosphate dehydro-
genase) as an internal control and calculated using the DDct-
method. The primer sequences are listed in Table 5. GAPDH cDNA
amplification was used as an internal standard. In the analyses, 10
transgenic (5 male mice 4–8 weeks old and 5 female mice 4–7 weeks
old) and 6 wild-type mice (2 male animals aged 4 and 8 weeks and
4 female animals aged between 4 and 6 weeks) were included.
Renal morphology and immunohistochemical analysis
Urinary protein concentrations were measured using the VITROS
Chemistry UPRO Slides and the VITROS chemistry products
calibrator kit 10 in the ‘Vitros 250’ system (OrthoClinical
Diagnostics, Neckargemuend, Germany). In all, 10 hemizygous
transgenic mice with urinary protein concentrations 4100 mg/dl
(5 male mice (4–8 weeks old) and 5 female mice (4–7 weeks old))
and 22 randomly selected wild-type mice (12 male animals aged
4–8 weeks and 10 female animals aged between 4 and 8 weeks) were
used for the immunohistochemical analyses. Cohorts of 7 mice
(4 hemizygous and 3 wild type) aged 2 weeks, 18 mice (4 proteinuric
and 9 nonproteinuric hemizygous and 5 wild type) aged 4 weeks,
and 29 mice (7 proteinuric and 12 nonproteinuric hemizygous and
10 wild type) mice aged 6 weeks were analyzed for glomerular
PCNA-positive cells. An additional 18 mice (12 hemizygous and
6 wild type) aged 6 weeks were injected intraperitoneally with
BrdU (100 mg/g body weight, Sigma) on three successive days
before killing.
Table 5 | Primers for real-time RT-PCR
Primers for detection with SybrGreen (qPCR Core Kit for SYBR Green I)
Gene Forward primer Reverse primer
GAPDH GGCAAATTCAACGGCACAGT AGATGGTGATGGGCTTCCC
Nephrin ACCCTCCAGTTAACTTGTCTTTGG ATGCAGCGGAGCCTTTGA
MCP-1 TGGCTCAGCCAGATGCAGT ATTGGGATCATCTTGCTGGTG
RANTES AGTGCTCCAATCTTGCAGTCG CACTTCTTCTCTGGGTTGGCA
CCR-2 TGTGATTGACAAGCACTTAGACCA ATGACAGGATTAATGCAGCAGTGT
VEGF (total) TCTTCAAGCCGTCCTGTGTG CTCCAGGGCTTCATCGTTACA
KDR-1 TGGATTCCTACCAGTATGGGACC TCTAGCTGCCAGTACCACTGGA
FLT-1 (total) CTGTCCATGAAAGTGAAGGCC CATGTACCAAATAGCGAGCAGACT
sFLT-1 GGTGAGCACTGCGGCAAAAAG TTAATGTTTGACATGACTTTGTGTGG
Primers for detection with Taqman probe (qPCR Core Kit)
Gene Forward primer Reverse primer Probe
GAPDH GGCAAATTCAACGGCACAGT AGATGGTGATGGGCTTCCC AAGGCCGAGAATGGGAAGCTTGTCATC
PDGF-A ACTTCCTGATCTGGCCCCC TGAAGGCTGGCACTTGACG TGTGGAGGTGAAGCGCTGCACTG
PDGF-B CCATCCGCTCCTTTGATGAT AAGTCCAGCTCAGCCCCAT CGCCTGCTGCACAGAGACTCCGTA
PDGF-C CTGGTGTGGAGATTAGTTGCAGTAG CCAGCCCAAATCTCTCATCAA TGAAAATGTGCGGATCCAGCTGACA
PDGF-D GACACTTTTGCGACTCCGC TGTGAGGTGATTGCTCTCATCTC TTGCGCAATGCCAACCTCAGGA
PDGFR-a´ AACGGAACCTTCAGCGTGG AACTCGCTGGTCTTGAACGTC CCTTACATCTGTGAGGCCACCGTCAAA
PDGFR-aˆ GAGGCTTATCCGATGCCTTCT AAACTAACTCGCCAGCGCC CCTGTGGCTCAAGGACAACCGTACCTT
PDGF-D/EGFP CATGGTGGCGACCGGT CAGTTGGATCATCATGAGCGA AATCGAGGTGGTCTTGAGCTGCAGATG
Col4a1 GGCGGTACACAGTCAGACCAT TGGTGTGCATCACGAAGGA TCCGCAGTGCCCTAACGGTTGGT
Fibronectin GATGGAATCCGGGAGCTTTT TGCAAGGCAACCACACTGAC CCGGCCTGAGGCCCTGCAG
Podocin CAGCTGGGCTTCAGCACTCT CCGCACTTTGGCCTGTCTT TGGCGGTGGAAGCTGAGGCAC
EGFP TACCTGAGCACCCAGTCCG CTTGTACAGCTCGTCCATGCC AAAGACCCCAACGAGAAGCGCGATC
Abbreviations: CCR-2, chemokine (C-C motif) receptor 2; Col4a1, collagen, type IV, alpha 1; EGFP, enhanced green fluorescent protein; FLT-1, fms-related tyrosine kinase 1;
GAPDH, glyceraldehyde 3-phosphate dehydrogenase; KDR-1, kinase insert domain receptor-1; MCP-1, monocyte chemotactic protein-1; PDGF, platelet-derived growth factor;
PDGFR, platelet-derived growth factor receptor; RANTES, regulated upon activation, normal T-cell expressed, and secreted; RT-PCR, reverse transcriptase-PCR; sFLT-1, soluble
fms-like tyrosine kinase-1.
All sequences are listed in 50 to 30 direction.
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Tissue for light microscopy was fixed in methyl Carnoy’s solution
and embedded in paraffin. Sections (4mm) were stained with
periodic acid-Schiff reagent and counterstained with hematoxylin.
Immunohistochemical analyses were performed following a pre-
viously published protocol.30 Renal tissues were stained using the
following antibodies:
K rabbit polyclonal anti-human fibrinogen (A0080, Dako, Hamburg,
Germany),
K rabbit polyclonal anti-rat fibronectin (AB 1954, Chemicon,
Hampshire, UK),
K goat polyclonal anti-human collagen type I (1310-01, Southern
Biotech, Birmingham, AL),
K mouse monoclonal anti-human a-smooth muscle actin, horse-
radish peroxidase-tagged (clone 1A4, Dako),
K rabbit polyclonal anti-human WT-1 antibodies (C-19, sc-192,
Santa Cruz, Santa Cruz, CA),
K rat polyclonal anti-human anti-CD3 (MCA1477, Serotec,
Oxford, UK),
K rat monoclonal anti-mouse anti Ly-6G (RB6-8C5, BD Bioscience,
San Jose, CA),
K rat monoclonal anti-mouse anti-ER-HR3 (T2012, Biomedicals,
Augst, Switzerland),
K rabbit polyclonal anti-human IgG (F0202; Dako),
K rabbit polyclonal anti-human IgA (A0262; Dako),
K rabbit polyclonal anti-human IgM (F0203; Dako),
K rabbit polyclonal anti-human C3c (F0201; Dako),
K mouse monoclonal anti-human PCNA, biotinylated (PC-10,
Oncogene, San Diego, CA), and
K mouse monoclonal anti-BrdU (BMC9318; Chemicon).
Negative controls for the immunohistochemical procedures con-
sisted of substitution of the primary antibody with nonimmune IgG.
Glomerulosclerosis scores were determined in periodic acid-
Schiff-stained sections as follows: score 0, no glomerulosclerosis;
score 1, 0.1–25% of the glomerular area with sclerotic changes; score
2, 25.1–50%; score 3, 50.1–75%; and score 4, 75.1–100%. For WT-1,
CD3, Ly-6G, ER-HR3, and PCNA staining, positively stained cells
per 50 randomly selected glomerular cross-sections were counted.
For the quantification of positively stained glomerular areas,
renal tissues were evaluated by computer-based morphometry using
the analysis v3.1 software (Soft imaging System GmbH, Mu¨nster,
Germany). In all analyses, the investigator was unaware of the origin
of the slides.
Electron microscopy
Tissue for electron microscopy was fixed in half-strength
Karnovsky’s solution (1% paraformaldehyde and 1.25% glutaral-
dehyde in 0.1 mol/l sodium cacodylate buffer, pH 7.0). After
fixation, the tissue was postfixed in 1% osmium tetroxide for 2 h,
dehydrated in graded ethanols, and embedded in epoxy resin. Thin
sections were stained with uranyl acetate and lead citrate and
examined with a Phillips 410 electron microscope (Phillips Export,
Eindhoven, The Netherlands). Kidney tissue examined included at
least two and usually three or more glomeruli per animal, as well
as cortical and medullary interstitium, tubules, and blood vessels.
Immunoprecipitation and western blot analysis
Protein extracts from kidneys of transgenic or wild-type mice were
obtained as described before.31 Before immunoprecipitation, anti-
GFP antibody (Alpha Diagnostic, San Antonio, TX) was covalently
linked to Protein A Sepharose beads. For this, 20mg of monoclonal
antibody was incubated with 300ml Protein A-Sepharose (50%
suspension, Invitrogen) for 1 h at room temperature. Pelleted beads
(3000 g, 5 min) were washed twice with sodium borate (0.1 mol/l,
pH 9.0) and dimethylpimelidate (Sigma) was added at a final
concentration of 20 mmol/l. After 30 min of incubation at room
temperature, beads were spun down, washed once in ethanolamine
(0.2 mol/l, pH 8.0), and subsequently incubated for 2 h in
ethanolamine at room temperature. Beads were separated from
unbound antibodies and resuspended in 120 ml phosphate-buffered
saline containing 0.03% sodium azide.
Immunoprecipitation was performed as described before.32
Briefly, 2 mg of protein extract was precleared with 10ml of Protein
A-Sepharose and subsequently incubated overnight at 4 1C with 40ml
of anti-GFP antibodies covalently linked to Protein A-Sepharose
beads. Beads were pelleted, washed intensively, and bound proteins
were resolved by sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis using a gradient gel (4–15%), followed by immunoblotting
with an affinity-purified polyclonal rabbit anti-PDGF-D antibody
(a kind gift from U Eriksson, Stockholm, Sweden).
Glomeruli, isolated from transgenic or wild-type mice, were
lysed and analyzed by sodium dodecyl sulfate-polyacrylamide gel
electrophoresis, and immunoblotting was performed as described5
using a mouse monoclonal anti-EGFP antibody (Clontech, clone
JL8) and a horseradish peroxidase-conjugated anti-mouse secondary
antibody (vector).
TUNEL staining
TUNEL staining was performed in methacarn-fixated tissues using
the ApopTag Plus fluorescein in situ apoptosis detection kit
(Chemicon) according to the manufacturer’s instructions.
Statistical analysis
All values were expressed as means±s.d. Two-tailed tests as
appropriate were used to compare the groups; that is, Student’s
t-test, Mann–Whitney U-test, or one-way analysis of variance with
Bonferroni post hoc analysis. Statistical significance was defined as
Po0.05.
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